Mario Balsa/X
Jul 4, 2025, 10:09
Mario Balsa: Climbing Towards a New SoC in Gastroesophageal Adenocarcinoma
Mario Balsa, Medical Oncology Resident at ICO, shared a post on X:
“Non-metastatic gastroesophageal adenocarcinoma – shifting landscape at ESMOGI25
– FLOT > CROSS for OS
– ↓ distant relapses with FLOT
– Peri-op IO rising: MIGHTY MATTERHORN!
– RT and adjuvant IO have lost ground
Climbing towards a new SoC — the Matterhorn is in sight!”
Read ESMO GI 2025 Highlights on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 4, 2025, 10:09
Jul 4, 2025, 09:39
Jul 4, 2025, 09:28
Jul 4, 2025, 09:25
Jul 4, 2025, 09:22
Jul 4, 2025, 09:11